Jesse Pines, MD
Integrative Medicine · Washington, DCNPI 1891742953
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $240,217 of the $350,018 with a category attached, or 68.6%. CSL Behring accounts for 81.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $86,158 and has fallen 53.4% since, to $40,111 in 2025.
Across 324 payments — averaging $1080.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$284K
- Abbott$31K
- Novo Nordisk$14K
- Boehringer Ingelheim$6K
- Eagle Pharmaceuticals, Inc.$4K
- AstraZeneca$4K
- plus $7K from 6 others
Across 3 payments — averaging $140,083 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Scientific Affairs, LLC$420K
What the payments were for
- Consulting fees$58,36417%
- Speaking & faculty fees$240,21769%
- Travel & lodging$45,03913%
- Food & beverage$6,3382%
- Education$610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 277 | $284,158 |
| Abbott | 18 | $30,795 |
| Novo Nordisk | 4 | $13,860 |
| Boehringer Ingelheim | 6 | $6,177 |
| Eagle Pharmaceuticals, Inc. | 6 | $4,386 |
| AstraZeneca | 5 | $3,994 |
| Medtronic(2 entities) | 2 | $2,978 |
| Beckman Coulter, Inc. | 2 | $1,575 |
| Kowa Pharmaceuticals America, Inc. | 1 | $1,185 |
| Orion Corporation | 1 | $500 |
| Baxter Healthcare | 1 | $350 |
| Tersera Therapeutics LLC | 1 | $61 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kcentra$281,258
- Alinity i-STAT TBI Plasma test$12,600
- NovoSeven RT$10,340
- i-STAT portable clinical analyzer$10,149
- I-STAT$7,650
- Berinert$4,987
- ANDEXXA$3,890
- NovoSeven$3,520
- DXH 900$1,575
- Seglentis$1,185
- Non-Franchise (NOF) - NonProduct$350
- i-STAT 1$110
How this compares
Too few integrative medicine providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.